Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Functions of the Gut Microbiota

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evolving epigenomics of immune cells at single-nucleus resolution in children en route to type 1 diabetes.

Nature communications·2026

Same author

Single-cell RNA-seq analysis of longitudinal CD4<sup>+</sup> T cell samples reveals cell-type-specific changes during early stages of type 1 diabetes.

Genome medicine·2025

Same author

Evolving epigenomics of immune cells in type 1 diabetes at single nuclei resolution.

Research square·2025

Same author

High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes-The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study.

The Journal of nutrition·2024

Same author

Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD.

ERJ open research·2023

Same author

Infant Feeding, Gut Permeability, and Gut Inflammation Markers.

Journal of pediatric gastroenterology and nutrition·2023

Search research articles

Related Experiment Video

Updated: May 10, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Gut microbiota and type 1 diabetes.

¹Immune Response Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland. outi.vaarala@thl.fi

The Review of Diabetic Studies : RDS

|June 28, 2013

Summary

Gut microbiota influence the immune system and may play a role in autoimmune diabetes. Altered gut bacteria are linked to type 1 diabetes, suggesting microbiota as a prevention target.

Area of Science:

Immunology
Microbiology
Endocrinology

Background:

The gut immune system is crucial for autoimmune diabetes development.
Gut microbiota modulate both innate and adaptive immunity, influencing immune cell function.
Immunological connections between the gut and pancreas, like shared lymphocyte homing receptors, link gut health to pancreatic autoimmunity.

Purpose of the Study:

To explore the role of gut microbiota in the development of autoimmune diabetes.
To investigate the association between gut microbiota composition and beta-cell autoimmunity.
To identify gut microbiota as potential targets for type 1 diabetes prevention.

Main Methods:

Review of animal studies demonstrating the impact of gut microbiota alterations (e.g., via antibiotics) on autoimmune diabetes.

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Related Experiment Videos

Last Updated: May 10, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Analysis of human studies examining fecal microbiota composition in individuals with type 1 diabetes.

Investigation of the role of toll-like receptor (TLR) signaling in mediating microbial effects on diabetes.

Main Results:

Animal studies show changes in gut microbiota composition can alter autoimmune diabetes development.
Human studies suggest an association between the abundance of Bacteroides and a lack of butyrate-producing bacteria with type 1 diabetes.
Deficient TLR signaling, influenced by microbiota, appears to prevent autoimmune diabetes.

Conclusions:

Altered gut microbiota may contribute to immunological dysregulation observed in type 1 diabetes.
Changes in gut microbiota could lead to increased gut permeability, inflammation, and impaired tolerance, factors implicated in type 1 diabetes.
Gut microbiota represent a promising, novel target for the prevention of type 1 diabetes.